Alok Chaturvedi
Business, Management and Accounting · Purdue University West Lafayette
Publications
137
Citations
1,559
Est. group size
—
Recurring co-author estimate
Active years
39
Publishing since 1987
The publication record attributed to this name appears to mix at least two distinct research identities: a small set of items related to business/economics topics (digital platforms, pricing, simulation, auction theory) and a much larger body of clinical and pharmaceutical research covering oncology drugs, dermatology, nephrology, and corrosion chemistry. Because the bibliographic data listed here is dominated by clinical trial reports, case studies, and meta-analyses in medicine rather than business or management research, this profile likely reflects a name-matching issue rather than a single coherent research program in Business, Management and Accounting.
Publication output rose from very low levels in 2017-2018 to a steadier pace of roughly 4-7 papers per year from 2019 through 2025, suggesting a generally steady to moderately growing publication cadence over the last decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Topical Tofacitinib for Atopic Dermatitis – Outcomes from Randomized Phase 3 Clinical Trial: First Approval
Indian Journal of Dermatology · 2025
- Efficacy and safety of nanosomal docetaxel lipid suspension in Indian patients with metastatic castration-resistant prostate cancer (mCRPC): A multicenter, open-label, single-arm phase 4 study.
Journal of Clinical Oncology · 2025
- Flupirtine – Back in Action? A Systematic Review and Meta-analysis of Its Efficacy and Safety in Low Back Pain Management
Indian Journal of Pain · 2025
- Effective management of a diabetic patient with hormone-receptor-positive, HER2‑negative metastatic breast cancer using nanosomal docetaxel lipid suspension for 12 cycles: A case report
Molecular and Clinical Oncology · 2025
- Treatment with nanosomal paclitaxel lipid suspension <i>versus</i> conventional paclitaxel in metastatic breast cancer patients – a multicenter, randomized, comparative, phase II/III clinical study
Therapeutic Advances in Medical Oncology · 2024
- #1904 Prevalence of osteoporosis in dialysis dependent CKD patients: a cross sectional study from India
Nephrology Dialysis Transplantation · 2024
- Efficacy and safety of Mirabegron plus Solifenacin combination therapy in comparison with Solifenacin monotherapy in Overactive bladder: A Systematic review and Meta-analysis
2024
- #1698731 Impact of Switching among Different Brands of Levothyroxine Tablet on Maintaining Normal Thyrotropin Levels: Results of a Prospective, Multicenter, Phase IV clinical trial
Endocrine Practice · 2024
- <p>Manufacturing-as-a-Service: Bringing Job Opportunities to the Base of the Pyramid<b></b></p>
SSRN Electronic Journal · 2024
- Comparison of the Pharmacokinetics, Bioequivalence and Safety of Aqueous Progesterone Formulation Administered as either Intramuscular or Subcutaneous Injection versus Oil-based Progesterone Formulation Administered as Intramuscular Injection: A Randomised Study
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 2023
- Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
OncoTargets and Therapy · 2023
- Study of Corrosion Inhibitory Effects of Alcoholic Extracts of <i>Tinospora Cordifolia</i> on Metal Tin in Acidic Media HCl with and without Additive (KCl)
Journal of Scientific Research · 2023
- Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
Journal of Clinical Oncology · 2023
- Corrosion Inhibition of Copper Metal by Ethanolic Extract of Tinospora Cordifolia Plant in Sulfuric and Hydrochloric Acids of varying Strength (0.5 N to 3N) using Additives
International Journal for Research in Applied Science and Engineering Technology · 2023
- #5534 HIFS AND BUTS: A NETWORK META-ANALYSIS OF HIF-PH INHIBITORS AND ESAS IN NDD-CKD PATIENTS WITH ANEMIA COMPARING THEIR SAFETY AND EFFICACY
Nephrology Dialysis Transplantation · 2023
- Ophthalmology and Therapy×3
- Bipolar Disorders×2
- International Journal of Research in Medical Sciences×2
- Nephrology Dialysis Transplantation×2
- Journal of Clinical Oncology×2
- Kannan Srinivasan
Business, Management and Accounting · The Ohio State University
- Mohammad Saifur Rahman
Business, Management and Accounting · Purdue University West Lafayette
- Koray Cosguner
Business, Management and Accounting · Indiana University
- Krista J. Li
Business, Management and Accounting · Indiana University
- Nil Karacaoglu
Business, Management and Accounting · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile